Biohit Oyj is a globally operating biotechnology company. Our company was established in 1988 and is listed on the Helsinki Stock Exchange. We develop innovative products and services to promote research and early diagnosis of GI tract conditions. Our product portfolio includes GastroPanel® for evaluation of stomach health, quick tests for detecting lactose intolerance, H. pylori infection, celiac disease, and colorectal cancer risk (ColonView®).
Business Needs: Distributor/Agent/Representative, Licensing Agreements
Products to be exported: IVD diagnostics (ELISA and quick tests) of gastrointestinal tract, and acetaldehyde binding products
Countries of Interest: Algeria, Argentina, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Germany, Guatemala, Honduras, Mexico, Nicaragua, Paraguay, Peru, Puerto Rico, Spain, Switzerland, United States, Uruguay